Xyrem (Jazz Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Xyrem drug offered from Jazz Pharmaceuticals, Inc.. This Central Nervous System Depressant [EPC],Central Nervous System Depression [PE],Decreased Central Nervous System Organized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Jazz Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | sodium oxybate |
| SUBSTANCE NAME: | SODIUM OXYBATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Central Nervous System Depressant [EPC],Central Nervous System Depression [PE],Decreased Central Nervous System Organized Electrical Activity [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2002-07-17 |
| END MARKETING DATE: | 0000-00-00 |
Xyrem HUMAN PRESCRIPTION DRUG Details:
| Item Description | Xyrem from Jazz Pharmaceuticals, Inc. |
| LABELER NAME: | Jazz Pharmaceuticals, Inc. |
| DEA SCHEDULE: | CIII
|
| ACTIVE STRENGTH: | 0.5(g/mL) |
| START MARKETING DATE: | 2002-07-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68727-100_9daded53-7bfe-46c0-9b7e-d87850a568dd |
| PRODUCT NDC: | 68727-100 |
| APPLICATION NUMBER: | NDA021196 |
Other SODIUM OXYBATE Pharmaceutical Manufacturers / Labelers:
